Top 5 Electric Utility Companies To Buy Right Now

Top 5 Electric Utility Companies To Buy Right Now: Theravance Inc.(THRX)

Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:

• [By Keith Speights]

  1. Anoro
  GlaxoSmithKline (NYSE: GSK  ) and Theravance (NASDAQ: THRX  ) gained approval from the Food and Drug Administration in May for COPD drug Breo Ellipta. However, the real excitement is over another drug that the two companies have in the wings -- Anoro.

• [By Sean Williams]

  The buzz in the health-care sector this week has nothing to do with earnings reports and everything to do with an expected PDUFA decision by the FDA on GlaxoSmithKline (NYSE: GSK  ) and Theravance's (NASDAQ: THRX  ) chronic obstructive pulmonary disease, or COPD, inhaled drug, Breo Ellipta.

• [By Keith Speights]

  Breathing easier
  Shares of Theravance (NASDAQ: THRX  ) popped 34% this week. The nice gains came after Theravance and partner GlaxoSmithKline (NYSE: GSK  ) announced that the FDA's Pulmonary-Allergy Drugs Advisory Committee voted 9-4 to recommend Breo Ellipta for approval.

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/top-5-electric-utility-companies-to-buy-right-now.html!